Texas lab to pay $5.9M to resolve kickback allegations

Austin-based Genotox Laboratories agreed to pay upward of $5.9 million to settle False Claims Act allegations related to third-party market commissions, the Justice Department said April 4.

Advertisement

The lab allegedly paid kickbacks to independent contractor sales representatives and marketing firms from 2014 to 2020, according to a news release. Under the settlement, Genotox “admitted and accepted responsibility” for paying them a portion of revenues received from billing Medicare, the Railroad Retirement Board and Tricare for lab testing orders facilitated or arranged by the representatives.

The settlement also resolves allegations that Genotox submitted claims to Medicare, the RRR and Tricare for tests that were not covered or not necessary from 2014 to 2022, the Justice Department said.

The lab will pay $5.9 million and additional money pending financial contingencies. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.